论文部分内容阅读
Background and Objective Mesenchymal stem cells (MSCs) are one of the optimal candidates for myocardial infarction.However, the survival ratio of implanted cells in the infarcted heart is low.Tongxinluo (TXL) is a traditional Chinese herbal medicine with multiple cardiovascular protective effects and has been widely used in China to treat patients with coronary heart disease.MEK/ERK pathway plays an important role in mediating cell survival.Therefore, we hypothesized that TXL could promote MSCs survival under hypoxia and serum deprivation (H/SD) via MEK/ERK pathway.